Lv1
70 积分 2026-01-08 加入
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
21小时前
待确认
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
13天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
13天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
14天前
已完结
Orforglipron: A Novel Oral GLP-1 Agonist for the Treatment of Obesity and Diabetes
14天前
已完结
Paraneoplastic syndromes review: The great forgotten ones
18天前
已完结
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
1个月前
已完结
Selection of Criteria in the Diagnosis Approach of Paraneoplastic Fever in Adults With Solid Neoplasia Using a Delphi Method
1个月前
已关闭
Selection of Criteria in the Diagnosis Approach of Paraneoplastic Fever in Adults With Solid Neoplasia Using a Delphi Method
1个月前
已关闭
Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model
1个月前
已完结
皖公网安备34019202002308
